Apoptosis in Huntington's disease
- PMID: 12657365
- DOI: 10.1016/S0278-5846(03)00021-6
Apoptosis in Huntington's disease
Abstract
Huntington's disease (HD) is an autosomal dominant, fatal disorder. Patients display increasing motor, psychiatric and cognitive impairment and at autopsy, late-stage patient brains show extensive striatal (caudate and putamen), pallidal and cortical atrophy. The initial and primary target of degeneration in HD is the striatal medium spiny GABAergic neuron, and by end stages of the disease up to 95% of these neurons are lost [J. Neuropathol. Exp. Neurol. 57 (1998) 369]. The disease is caused by an elongation of a polyglutamine tract in the N-terminal of the huntingtin gene, but it is not known how this mutation leads to such extensive, but selective, cell death [Cell 72 (1993) 971]. There is substantial evidence from in vitro studies that connects apoptotic pathways and apoptosis with the mutant protein, and theories linking apoptosis to neuronal death in HD have existed for several years. Despite this, evidence of apoptotic neuronal death in HD is scarce. It may be that the processes involved in apoptosis, rather than apoptosis per se, are more important for HD pathogenesis. Upregulation of the proapoptotic proteins could lead to cleavage of huntingtin and as recent data has shown, the consequent toxic fragment may itself elicit toxic effects on the cell by disrupting transcription. In addition, the increased levels of proapoptotic proteins could contribute to slowly developing cell death in HD, selective for the striatal medium spiny GABAergic neurons and later spreading to other areas. Here we review the evidence supporting these mechanisms of pathogenesis in HD.
Similar articles
-
Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.Hum Mol Genet. 2015 Nov 1;24(21):6066-79. doi: 10.1093/hmg/ddv318. Epub 2015 Aug 11. Hum Mol Genet. 2015. PMID: 26264576
-
Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.Neurobiol Dis. 2012 Oct;48(1):40-51. doi: 10.1016/j.nbd.2012.05.013. Epub 2012 Jun 2. Neurobiol Dis. 2012. PMID: 22668780
-
Functional interactions within striatal microcircuit in animal models of Huntington's disease.Neuroscience. 2012 Jun 1;211:165-84. doi: 10.1016/j.neuroscience.2011.06.075. Epub 2011 Jul 1. Neuroscience. 2012. PMID: 21756979 Review.
-
Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.J Neurochem. 2007 Jul;102(1):25-36. doi: 10.1111/j.1471-4159.2007.04491.x. Epub 2007 Mar 30. J Neurochem. 2007. PMID: 17403029
-
[Huntington disease. A review].Invest Clin. 2000 Jun;41(2):117-41. Invest Clin. 2000. PMID: 10961047 Review. Spanish.
Cited by
-
Longitudinal modeling of human neuronal aging reveals the contribution of the RCAN1-TFEB pathway to Huntington's disease neurodegeneration.Nat Aging. 2024 Jan;4(1):95-109. doi: 10.1038/s43587-023-00538-3. Epub 2023 Dec 8. Nat Aging. 2024. PMID: 38066314
-
Development of novel cytoprotective small compounds inhibiting mitochondria-dependent cell death.iScience. 2023 Sep 17;26(10):107916. doi: 10.1016/j.isci.2023.107916. eCollection 2023 Oct 20. iScience. 2023. PMID: 37841588 Free PMC article.
-
Apoptosis Genes as a Key to Identification of Inverse Comorbidity of Huntington's Disease and Cancer.Int J Mol Sci. 2023 May 27;24(11):9385. doi: 10.3390/ijms24119385. Int J Mol Sci. 2023. PMID: 37298337 Free PMC article.
-
ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington's disease.Genes Dev. 2023 Mar 1;37(5-6):204-217. doi: 10.1101/gad.350211.122. Epub 2023 Mar 15. Genes Dev. 2023. PMID: 36921996 Free PMC article.
-
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia.Antioxidants (Basel). 2022 Nov 17;11(11):2275. doi: 10.3390/antiox11112275. Antioxidants (Basel). 2022. PMID: 36421461 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical